Efficacy of safety of therapy with interferon alfa-2a plus ribavirin in HIV/HCV coinfected patients. Preliminary results of an open prospective study

被引：0
|
作者：
Galeras, JA
Tural, C
Force, L
Montoliu, S
de Castro, JAR
Coll, S
Fuster, D
Barrufet, P
Dominguez, MD
Planas, R
机构：
[1] Hosp del Mar, Hepatol Unit, Badalona, Spain
[2] Hosp Germans Trias & Pujol, Hepatol Unit, Badalona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
10.1016/S0168-8278(03)80753-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
487
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [1] The safety and efficacy of taribavirin plus pegylated interferon alfa-2a versus ribavirin plus pegylated interferon alfa-2a in therapy-naive patients infected with hcv: Phase 3 results
    Marcellin, P.
    Lurie, Y.
    Rodrigues-Torres, M.
    Chasen, R.
    Xu, Y.
    Murphy, B.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S7 - S7
  • [2] Open-label study of the safety and efficacy of interferon alfa-2b plus ribavirin for the treatment of HCV infection in HIV patients.
    Li, JJ
    Sanchez, N
    Monteiro, C
    Cubbedge, L
    Lambiase, LR
    [J]. HEPATOLOGY, 2001, 34 (04) : 588A - 588A
  • [3] Efficacy and safety of interferon and ribavirin therapy in HIV-HCV coinfected patients
    Zylberberg, H
    Benhamou, Y
    Chaix, ML
    Fontaine, H
    Rouzioux, C
    Katlama, C
    Poynard, T
    Bréchot, C
    Pol, S
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
  • [4] Early HCV-RNA clearance in HIV/HCV-coinfected patients treated with pegylated interferon alfa-2a plus ribavirin
    Camino, N
    Nuñez, M
    Romero, M
    Barreiro, P
    Ocampo, A
    Miralles, C
    Martín-Carbonero, L
    Fernández, A
    García-Samaniego, J
    Soriano, V
    [J]. HEPATOLOGY, 2004, 40 (04) : 402A - 403A
  • [5] Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
    Chung, RT
    Andersen, J
    Volberding, P
    Robbins, GK
    Liu, T
    Sherman, KE
    Peters, MG
    Koziel, MJ
    Bhan, AK
    Alston, B
    Colquhoun, D
    Nevin, T
    Harb, G
    van der Horst, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05): : 451 - 459
  • [6] Pegylated interferon alfa-2b and ribavirin in HIV/HCV-coinfected patients.
    Myers, RP
    Benhamou, Y
    Bochet, M
    Mehri, D
    Di Martino, V
    Valantin, MA
    Katlama, C
    Bricaire, F
    Poynard, T
    [J]. HEPATOLOGY, 2002, 36 (04) : 575A - 575A
  • [7] An open-label, multicenter study of efficacy and safety of peginterferon alfa-2a/ribavirin in HIV/HCV coinfection
    Ortega, E
    Barros, C
    Pulido, F
    Rubio, R
    Garcia, JA
    Aguirrebengoa, K
    Asensi, V
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 160 - 160
  • [8] Efficacy of interferon alpha-2b plus ribavirin combination therapy in HIV/HCV coinfected patients
    Oliver, DL
    Stewart, M
    Chatfield, E
    Aronson, N
    Selim, K
    Mathew, C
    Hassanein, T
    [J]. GASTROENTEROLOGY, 2002, 123 (01) : 77 - 77
  • [9] Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy
    Rodriguez-Torres, Maribel
    Rodriguez-Orengo, Jose F.
    Rios-Bedoya, Carlos F.
    Fernandez-Carbia, Alberto
    Gonzalez-Lassalle, Elsa
    Salgado-Mercado, Rosa
    Marxuach-Cuetara, Acisclo M.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2007, 38 (01) : 32 - 38
  • [10] Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial
    Rodriguez-Torres, Maribel
    Slim, Jihad
    Bhatti, Laveeza
    Sterling, Richard
    Sulkowski, Mark
    Hassanein, Tarek
    Serrao, Rosario
    Sola, Ricard
    Bertasso, Anne
    Passe, Sharon
    Stancic, Saray
    [J]. HIV CLINICAL TRIALS, 2012, 13 (03): : 142 - 152
12345